Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share Price

Price 1,851.00p on 25-09-2026 at 18:35:09
Change -26.00p -1.39%
Buy 1,856.00p
Sell 1,855.00p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 1,100.00 at 1,851.00p
Day's Volume: 6,920,309
Last Close: 1,851.00p
Open: 1,872.00p
ISIN: GB00BN7SWP63
Day's Range 1,851.00p - 1,891.00p
52wk Range: 1,495.00p - 2,282.00p
Market Capitalisation: £74.17b
VWAP: 1,863.60208p
Shares in Issue: 4.01b

Sector: Medicine and Biotech

Listed In: FTSE All-Share, FTSE All-Share ex Investment Trusts, FTSE Higher Yield, FTSE 350 ex Investment Trusts, FTSE 350 , FTSE 100,

Glaxosmithkline (GSK) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 1,100 1,851.00p Automatic Execution
 16:35:08 - 25-Sep-26
Sell* 20,371 1,851.00p Automatic Execution
 16:35:08 - 25-Sep-26
Sell* 775 1,851.00p Automatic Execution
 16:35:08 - 25-Sep-26
Sell* 532 1,851.00p Automatic Execution
 16:35:08 - 25-Sep-26
Sell* 2,570,460 1,851.00p Uncrossing Trade
 16:35:08 - 25-Sep-26
Sell* 334 1,856.00p Automatic Execution
 16:29:43 - 25-Sep-26
Buy* 985 1,856.00p Automatic Execution
 16:29:43 - 25-Sep-26
Buy* 579 1,856.00p Automatic Execution
 16:29:43 - 25-Sep-26
Buy* 7 1,856.00p Automatic Execution
 16:29:43 - 25-Sep-26
Unknown* 0 1,856.50p SI Trade
 16:29:14 - 25-Sep-26
See more Glaxosmithkline trades

Glaxosmithkline (GSK) Share Price History

Time period:
to
Date Open High Low Close Volume
25th Sep 2026 (Fri) 1,872.00 1,891.00 1,851.00 1,851.00 6,920,309
24th Sep 2026 (Thu) 1,873.00 1,896.00 1,863.00 1,877.00 3,578,575
23rd Sep 2026 (Wed) 1,895.50 1,912.50 1,874.50 1,886.00 6,310,501
22nd Sep 2026 (Tue) 1,913.50 1,913.50 1,881.00 1,906.00 5,135,262
21st Sep 2026 (Mon) 1,878.00 1,916.00 1,868.50 1,911.00 6,861,145
18th Sep 2026 (Fri) 1,907.00 1,912.00 1,852.50 1,877.50 15,668,260
17th Sep 2026 (Thu) 1,885.50 1,906.50 1,872.00 1,900.00 9,893,739
16th Sep 2026 (Wed) 1,855.50 1,883.50 1,853.50 1,865.50 7,165,366
15th Sep 2026 (Tue) 1,862.50 1,876.50 1,839.00 1,854.00 4,901,615
14th Sep 2026 (Mon) 1,800.00 1,870.00 1,789.50 1,854.50 4,365,126
11th Sep 2026 (Fri) 1,786.00 1,804.00 1,770.00 1,770.50 3,933,904
10th Sep 2026 (Thu) 1,800.00 1,803.50 1,775.50 1,775.50 3,018,164
9th Sep 2026 (Wed) 1,776.00 1,812.50 1,772.00 1,803.50 3,659,124
8th Sep 2026 (Tue) 1,824.00 1,829.50 1,782.00 1,796.50 5,349,814
7th Sep 2026 (Mon) 1,834.50 1,849.00 1,825.50 1,837.50 4,622,327
4th Sep 2026 (Fri) 1,866.00 1,869.00 1,835.50 1,846.50 3,782,286
3rd Sep 2026 (Thu) 1,871.00 1,911.00 1,858.50 1,866.50 4,089,291
2nd Sep 2026 (Wed) 1,874.00 1,889.50 1,851.00 1,861.50 4,977,182
1st Sep 2026 (Tue) 1,847.50 1,892.00 1,842.00 1,871.50 4,718,988
31st Aug 2026 (Mon) 1,853.50 1,853.50 1,853.50 1,853.50 0
28th Aug 2026 (Fri) 1,862.50 1,863.00 1,839.50 1,853.50 7,789,320
27th Aug 2026 (Thu) 1,890.00 1,902.00 1,852.00 1,852.00 3,594,159
See more Glaxosmithkline price history

Glaxosmithkline (GSK) Regulatory News

Date Source Headline
24th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
22nd Sep 2026 3:30 pm RNS Director/PDMR Shareholding
15th Sep 2026 7:00 am RNS GSK to acquire T cell-engager for multiple myeloma
14th Sep 2026 7:00 am RNS Ris-Rez Positive Ph 3 OS Lung Cancer Data in China
14th Sep 2026 7:00 am RNS Jideytro positive data for ROS1-positive NSCLC
11th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
10th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
10th Sep 2026 7:00 am RNS Japan approval of Shingrix in a prefilled syringe
9th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
9th Sep 2026 3:30 pm RNS Director/PDMR Shareholding
See more Glaxosmithkline regulatory news

Glaxosmithkline (GSK) Share News

LONDON MARKET CLOSE: FTSE 100 edges up as oil fall offsets bond worry

25th Sep 2026 17:04

(Alliance News) - Stocks in London made modest progress on Friday as lower oil prices amid hopes of progress in US-Iran negotiations helped offset concerns over another rise in bond yields. Read More

IN BRIEF: Hikma Pharmaceuticals appoints ViiV's Rebecca Hall as CFO

24th Sep 2026 09:10

Hikma Pharmaceuticals PLC - London-based pharmaceutical maker - Appoints Rebecca Hall as chief financial officer, effective from a to-be-announced date in the first quarter of 2027, which Hikma will confirm "in due course." Hall joins Hikma from ViiV Healthcare Ltd, a specialist HIV pharmaceutical company majority owned by GSK PLC, with pharma firm Shionogi & Co Ltd as a shareholder. At ViiV Healthcare, Hall is senior vice president and CFO, responsible for finance, supply chain and business development. Hikma Chair Victoria Hull said: "Becky's appointment is a further step in broadening the expertise we have across both the executive team and the board, positioning us well for long-term sustainable growth." Read More

Vault Ventures rebrands as Sentry 7, appoints new CEO

21st Sep 2026 12:19

(Alliance News) - Vault Ventures PLC on Monday announced a change of name and leadership as it moves towards bringing its first product to the market. Read More

LONDON BRIEFING: UK inflation rises; Barratt cuts completions outlook

16th Sep 2026 07:59

(Alliance News) - UK inflation accelerates to 3.1% in August as higher fuel costs drive prices higher. Barratt Redrow reports a rise in annual pretax profit but lowers its home completions guidance, while Babcock says trading is in line with expectations and leaves its outlook unchanged. Read More

LONDON BROKER RATINGS: Berenberg likes GSK; Deutsche Bank lifts Astra

15th Sep 2026 09:53

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

See more Glaxosmithkline news
FTSE 100 Latest
Value10,695.25
Change15.26

Login to your account

Forgot Password?

Not Registered